Brieuc S.
- Country
- Belgium
- Department
- Medical Oncology
Research Overview
- A Phase 2, Randomized, Open-Label Study of Two Dose Levels of Vobramitamab Duocarmazine in Participants with Metastatic Castration-Resistant Prostate Cancer (TAMARACK)
- Phase III Randomized Open‑Label Trial of BNT324 Versus Docetaxel Plus Prednisone in Metastatic Castration‑Resistant Prostate Cancer
- Phase 3 Study of Enfortumab Vedotin and Pembrolizumab Versus Chemotherapy in Untreated Locally Advanced or Metastatic Urothelial Cancer
Data & Insights
Has run more than one trial at 107 of 278 partner sites.
Specializations
Oncology – Solid Tumors
Focused on advanced breast cancer, lung cancer, and gastro‑intestinal malignancies with an emphasis on molecularly defined subgroups.
- Hormone‑receptor‑positive, HER2‑negative breast cancer
- KRAS‑G12C‑mutated non‑small cell lung cancer
- HER2‑expressing gastric and gastroesophageal junction adenocarcinoma
- Colorectal cancer with BRAF V600E mutation
- Advanced ovarian and fallopian tube carcinoma
Research supports targeted and immuno‑oncologic strategies for patients with limited treatment options.
Hematology – Malignant Blood Disorders
Investigations span acute and chronic leukemias, lymphomas, and plasma‑cell neoplasms.
- Acute myeloid leukemia (AML) with IDH1 mutation
- Acute lymphoblastic leukemia in young adults
- Diffuse large B‑cell lymphoma (DLBCL)
- Multiple myeloma, including relapsed/refractory disease
- Chronic lymphocytic leukemia (CLL)
Efforts aim to improve survival through novel agents and combination regimens.
Autoimmune & Inflammatory Disorders
Extensive work on systemic and organ‑specific autoimmune conditions.
- Systemic lupus erythematosus (SLE)
- Psoriatic arthritis
- Moderate‑to‑severe plaque psoriasis
- Rheumatoid arthritis
- Inflammatory bowel disease (Crohn’s disease and ulcerative colitis)
Therapeutic focus includes biologics and targeted immunomodulators.
Respiratory & Pulmonary Diseases
Key interests cover chronic obstructive pulmonary disease, interstitial lung disease, and acute respiratory syndromes.
- Chronic obstructive pulmonary disease (COPD)
- Idiopathic pulmonary fibrosis (IPF)
- Systemic sclerosis‑associated interstitial lung disease
- Severe asthma
- Acute respiratory distress syndrome (ARDS)
Research targets disease progression and lung function preservation.
Metabolic, Renal & Cardiovascular Health
Investigations address metabolic dysfunction, kidney disease, and cardiovascular risk.
- Non‑alcoholic steatohepatitis (NASH)
- Chronic kidney disease (CKD) with hypertension
- Obesity and overweight associated with ASCVD
- Type 2 diabetes prevention
- Alport syndrome and focal segmental glomerulosclerosis
Therapeutic development seeks to modify disease pathways and improve organ outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
